IHS Chemical Week

Regions :: North Asia :: Japan

Sumitomo Chemical to sell its stake in AstraZeneca’s Japan unit

12:17 AM MST | February 28, 2014 | Deepti Ramesh

Sumitomo Chemical says that it has decided to sell its 20% stake in AstraZeneca K.K. (Osaka, Japan) to AstraZeneca (London). AstraZeneca K.K., which was established in 1975, develops, manufactures, and markets pharmaceuticals. Following Sumitomo’s exit, AstraZeneca will have full ownership of AstraZeneca K.K. With the sale, Sumitomo aims to further strengthen its financial base, the company says. In the fiscal year ending 31 March, Sumitomo expects to post an extraordinary gain of about ¥10 billion ($98 million) on a nonconsolidated basis, from the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa